Wednesday, December 24, 2014

10 Best Diversified Bank Stocks To Invest In 2014

The U.S. Energy Department's weekly inventory release showed an in-line rise in natural gas supplies, as the commodity�� brisk use for power generation in the face of summer temperatures were offset by strong production growth. However, on a bearish note, the build was ahead of the five-year average levels, thereby narrowing the deficit with the benchmark.

About the Weekly Natural Gas Storage Report

The Weekly Natural Gas Storage Report ��brought out by the Energy Information Administration (EIA) every Thursday since 2002 ��includes updates on natural gas market prices, the latest storage level estimates, recent weather data and other market activities or events.

The report provides an overview of the level of reserves and their movements, thereby helping investors understand the demand/supply dynamics of natural gas. It is an indicator of current gas prices and volatility that affect businesses of natural gas-weighted companies and related support plays.

Top 10 Small Cap Stocks To Buy Right Now: Oplink Communications Inc.(OPLK)

Oplink Communications, Inc., together with its subsidiaries, designs, manufactures, and sells optical networking components and subsystems worldwide. The company?s products are used to expand optical bandwidth, amplify optical signals, monitor and protect wavelength performance, redirect light signals, ensure signal connectivity, and provide signal transmission and reception within an optical network. It offers bandwidth creation products, such as wavelength expansion products comprising dense wavelength division multiplexers (DWDM), coarse wavelength division multiplexers, band wavelength division multiplexers, and DWDM interleavers; and optical amplification products consisting of gain blocks, erbium doped fiber amplifiers, wavelength division multiplexers pump/signal combiners, integrated hybrid components, WDM pump combiners, polarization beam combiners, gain flattening filters isolators, isolators, and tap couplers. The company also offers bandwidth management produc ts, such as optical switching and routing products comprising optical add/drop multiplexers, wavelength selective switches, reconfigurable OADMs, switches, and circulators; wavelength conditioning products that include variable optical attenuators, variable multiplexers, and dynamic band equalization products; and wavelength performance monitoring and protection products consisting of supervisory channel WDM, integrated WDM and tap monitor arrays, optical channel monitors, and wavelength protection subsystems. In addition, it provides optical interconnect products, including connectors and adapters, fixed attenuators, patchcords, and termination and distribution enclosures; and transmission products, such as small form-factor pluggable transceivers, XFP transceivers, CWDM transceivers, bi-directional transceivers, DWDM transceivers, optical supervisory channel transceivers, GEPON products, and 40G/100G transceiver products. The company was founded in 1995 and is headquartere d in Fremont, California.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Oplink Communications (Nasdaq: OPLK  ) , whose recent revenue and earnings are plotted below.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Oplink Communications (Nasdaq: OPLK  ) , whose recent revenue and earnings are plotted below.

10 Best Diversified Bank Stocks To Invest In 2014: AbbVie Inc (ABBV)

AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a research-based pharmaceuticals company. The Company discovers, develops, and commercializes advanced therapies. AbbVie's portfolio of products include a line of adult and pediatric pharmaceuticals, which includes HUMIRA, metabolics/hormones products, virology products, endocrinology products, dyslipidemia products and other products.

AbbVie products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, human immunodeficiency virus (HIV), cystic fibrosis complications, low testosterone, thyroid disease, Parkinson's disease and complications associated with chronic kidney disease, among other indications. In October 2012, AbbVie initiated a comprehensive Phase III program for hepatitis C virus (HCV) genotype one.

Advisors' Opinion:
  • [By Ben Levisohn]

    Gilead Sciences is down ~4% this morning and some investors believe it is due to commentary by Johnson & Johnson (JNJ) (we were on the EPS call and they did not say anything specific, they just said they will work to make Olysio accessible and it will remain competitive, some investors think Olysio price will get cut — but, in our view, logically – if Sovaldi is still $84k, then Olysio does not have much of any room to go if you can just get Harvoni for $94k…..). Others think it is due to concerns around AbbVie (ABBV) needing to come in a low price (we predict this will not happen, it will be close to Sovaldi pricing) or Irish tax concerns, which we wrote about twice suggesting minimal impact here to Gilead Sciences.

  • [By Garrett Cook]

    AbbVie (NYSE: ABBV) lifted its offer to buy Shire plc (NASDAQ: SHPG) to 30.1 billion pounds ($51.3 billion).

    The latest offer for Shire is approximately an 11 percent increase from the previous bid. The new offer stands at £22.44 cash and 0.8568 AbbVie shares for each Shire share, or £51.15 total.

  • [By Shauna O'Brien]

    On Tuesday, AbbVie Inc (ABBV) released phase III results from the SAPPHIRE-II study, which is the second of six phase 3 studies for the treatment of the hepatitis C virus (HCV) genotype 1 (GT1) infection.

    AbbVie reported that in the study, which included 394 patients, 96% of those who has previously failed pegylated interferon and ribavirin treatment in the past sustained virologic response at 12 weeks with the regimen.

    There are 160 million infected with hepatitis C worldwide. ABBV’s HCV program is currently the largest all oral, interferon-free clinical program in GT1 patients being conducted.

    AbbVie shares were mostly flat during Tuesday morning trading. The stock is up 50% YTD.

  • [By Maxx Chatsko]

    After spinning off its pharmaceutical business -- and most of its dividend, essentially -- you may think Abbott Laboratories (NYSE: ABT  ) is relegated to a boring medical-device company. Heart stents just aren't as sexy as the megablockbuster drugs now being wielded by AbbVie� (NYSE: ABBV  ) . The spinoff also took a promising�pipeline and most of the former company's dividend, which may make investors think twice about owning a slow-growing, mediocre-paying company such as Abbott.�

10 Best Diversified Bank Stocks To Invest In 2014: Safran SA (SAF)

Safran SA is a France-based high-technology company which produces aircraft and rocket engines and propulsion systems. It divides its work into three segments: Aerospace, Aircraft, Defense and Security. The Aerospace Propulsion division provides engines, turbines and parts for aircraft, and rocket boosters for civil, military and spatial markets through several subsidiaries, including Snecma, among others. The Aircraft Equipment division produces landing gear, wheels and carbon brakes, aircraft engine nacelles and airborne power electronics through its subsidiaries, including Aircelle, among others. The Defense division includes the subsidiary, Sagem, and makes systems and equipment for inertial navigation and other defense applications to be used on military transport and combat aircraft, helicopters, warships, armored vehicles and artillery systems. In October 2013, the Company completed the sale of its United States-based subsidiary, Global Motors Inc to Allied Motion Inc. Advisors' Opinion:
  • [By Sofia Horta e Costa]

    Vivendi SA climbed 2.7 percent after posting better-than-estimated third-quarter profit and saying it plans to spin off its French phone carrier SFR by July 2014. Serco Group Plc (SRP) increased 1.7 percent as UBS AG upgraded the stock. Safran SA (SAF) lost 3.2 percent as its largest shareholder sold a stake.

10 Best Diversified Bank Stocks To Invest In 2014: ML Capital Group Inc (MLCG)

ML CAPITAL GROUP. INC., incorporated on September 27, 2009, is an exploration-stage company. The Company was engaged in conducting assistance with financing needs of MicroCap corporations.

The Company is focused on research on line, attend trade shows and contact its associates in several industries. As of September 7, 2011, the Company had not generated revenue.

Advisors' Opinion:
  • [By Peter Graham]

    Small cap marijuana stocks IMD Companies Inc (OTCMKTS: ICBU), Tauriga Sciences Inc (OTCMKTS: TAUG), ML Capital Group Inc (OTCBB: MLCG) and Lexaria Corp (OTCMKTS: LXRP) are aiming to give investors a high with their latest news. However, only one of these small cap marijuana stocks appears to be the subject of minor paid promotion or investor relations type of activities. So will investors and traders alike get a high off of these small caps? Here is a quick reality check:

10 Best Diversified Bank Stocks To Invest In 2014: U.S. Silica Holdings Inc (SLCA)

US Silica Holdings, Inc. is a silica sand supplier company. The Company is a producer of industrial minerals, including sand proppants, whole grain silica, ground silica, fine ground silica, calcined kaolin clay and aplite clay. The Company operates in two segments: oil and gas, and industrial and specialty products. The Company�� shipping capabilities include five of the class-one railroads, barge, full truckload, partial truckload and intermodal. The Company�� products include proppants, whole grain silica, ground silica, fine ground silica, testing silica, recreational silica, aplite, kaolin, hydrous kaolin and FLORISIL. It also operates as a research and development specialist for customized products and solutions. The Company serves a range of industries and applications, which includes oil and gas, glass, chemicals, foundry, building products, fillers and extenders, recreation, industrial filtration and treatment, and testing and analysis.

Oil & Gas

The Company�� oil and gas segment include OTTAWA WHITE and SHALE FRAC product lines. The Company has a selection of offerings from number of mining and transload locations. Its products consist of unconventional reservoirs, including tight gas, coal bed methane, shale gas, and liquids.

Industrial & Specialty Products

The Company�� industrial and specialty products include glass, chemical, foundry, building products, fillers and extenders, recreation, industry filtration and treatment, and testing and analysis. The Company produces a range of whole grain silica, ground silica and kaolin clays.

Advisors' Opinion:
  • [By Matt DiLallo]

    Risks
    An investment in Hi-Crush is not without risks. It's not as diversified as rival�U.S. Silica Holdings� (NYSE: SLCA  ) ,�which has pursued a strategy that has it boasting over 200 products and 1,400 customers. Hi-Crush has just a handful of customers and one main product. Meanwhile, U.S. Silica is much more geographically diverse with 15 facilities compared to just two for Hi-Crush. I like the fact Hi-Crush is a pure play; however, being concentrated is a big risk, which is one reason why I'm writing puts to buy units much cheaper.�

10 Best Diversified Bank Stocks To Invest In 2014: KKR(KKR)

Kohlberg Kravis Roberts & Co. is a private equity and venture capital firm specializing in acquisitions, leveraged buyouts, management buyouts, and mezzanine investments in large cap companies. The firm will consider investments in all industries globally, with a focus on financial services, infrastructure, and renewable energy. It seeks a board seat in its portfolio companies. The firm holds a controlling interest in its portfolio companies after they go public. It typically holds its investment for a period of five years and more and exits through initial public offerings, secondary offerings, and sales to strategic buyers. Kohlberg Kravis Roberts & Co. was founded in 1976 and is based at New York, New York with additional offices across United States, Europe, Australia, and Asia.

Advisors' Opinion:
  • [By Eric Volkman]

    KKR (NYSE: KKR  ) is getting into the car business, to a certain extent. The storied private equity firm has reached an agreement to take a controlling stake in Alliance Tire Group, a multinational manufacturer of off-highway tires. The seller is fellow private equity operator Warburg Pincus. The terms of the deal were not disclosed.

  • [By Vera Yuan]

    The top contributing stock for the quarter was Treasury Wine Estates (ASX:TWE), an Australian-based vineyard operator and winemaker that also has significant assets in North America, as well as a global marketing and distribution business. During the quarter Treasury Wine Estates received a preliminary, highly conditional bid from a global investment firm, Kohlberg Kravis Roberts (KKR), to purchase the company for AUD 4.70 per share. The bid was rejected, with management stating that the per-share offer amount undervalued the company. However, the board of directors indicated that the company would consider any new proposals that reflected a price closer to their perception of fair value. Discussions with KKR have since ended without any subsequent offers. We believe that management made the correct decision, as we too feel that the business value of Treasury Wine Estates is worth more than what KKR offered. We recently spoke with Treasury�� Chairman, Paul Rayner, and new CEO, Michael Clarke, with regard to this issue, in addition to recent management changes and a new AUD 35 million cost-cutting program, and we are confident that the company�� leadership team has been substantially improved and is working to increase Treasury Wine Estates��overall value for the benefit of shareholders.

  • [By Reuters]

    Itsuo Inouye/APA Panasonic 150-inch high-definition plasma TV on display at a 2008 expo in Tokyo. TOKYO -- Panasonic will pull out of the plasma television panel business by the end of the financial year to March 2014, sources familiar with the situation told Reuters, marking a key milestone in the long-term decline of Japan's TV industry. Panasonic had been widely expected to back out of the unprofitable business, but the exit comes sooner than predicted and underlines President Kazuhiro Tsuga's determination to weed out weak operations as he focuses on higher-margin products to end years of losses at the consumer electronics conglomerate. Panasonic's TV division has been a major contributor to the electronics company's combined $15 billion (9 billion pounds) net loss in its two latest financial years. Its TV business posted an operating loss of 88.5 billion yen ($913 million) in the last financial year. With the closure of its sole plasma panel factory in western Japan, Panasonic will book an impairment loss of more than 40 billion yen on the last remaining factory building in operation, the sources added. The company set aside 120 billion yen to cover restructuring costs at the start of the current financial year. The move also signals the demise in Japan of a technology in which TV makers once invested heavily but has now been overtaken by advances in the liquid crystal display business. Plasma display TVs accounted for less than 6 percent of global shipments in 2012, compared with 87 percent for LCD TVs, according to research firm DisplaySearch. Squeezed by the strong yen in recent years, Japan's TV makers have also lost their innovative edge against nimbler rivals such as South Korea's Samsung Electronics, with deep resources to spend on research and development. Sony (SNE), Panasonic and Sharp combined had a less than 20 percent share of the worldwide flat panel TV market by revenue. Samsung had a 27.7 percent share, and LG Electronics had 15 pe

10 Best Diversified Bank Stocks To Invest In 2014: Dassault Systemes SA (DSY)

Dassault Systemes SA provides software solutions and consulting services. The Company�� global customer base includes companies primarily in 11 industrial sectors: Aerospace & Defense, Transportation & Mobility, Marine & Offshore, Industrial Equipment, High Tech, Architecture, Engineering & Construction, Consumer Goods Retail, Consumer Packaged goods Retail, Life Sciences, Energy, Process & Utilities, Financial & Business services. To serve these industries, the Company has developed a broad software applications portfolio, organized in brands, in order to provide comprehensive solutions responding to the extensive requirements of product development: Design, Realistic Simulation, Virtual Manufacturing and Production, Collaborative Innovation, Lifelike Experiences and Information Intelligence. In July 2013, it acquired Apriso. In September 2013, it acquired Safe Technology Ltd. In January 2014, the Company acquired 84% interest in Realtime Technology AG. Advisors' Opinion:
  • [By Julia Leite]

    The FTSE/JSE Africa All Shares Index fell 1.8 percent, the most since July 5. Discovery Ltd. (DSY), South Africa�� largest medical-insurance provider, sank 9.1 percent after saying profit will be as much as 10 percent lower than the previous period.

No comments:

Post a Comment